Jonathan D. Bargh

1.3k total citations · 2 hit papers
9 papers, 1.0k citations indexed

About

Jonathan D. Bargh is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Jonathan D. Bargh has authored 9 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Jonathan D. Bargh's work include HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Click Chemistry and Applications (3 papers). Jonathan D. Bargh is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Click Chemistry and Applications (3 papers). Jonathan D. Bargh collaborates with scholars based in United Kingdom, Brazil and Sweden. Jonathan D. Bargh's co-authors include David R. Spring, Albert Isidro‐Llobet, Jeremy S. Parker, Nicola Ashman, Stephen J. Walsh, Jason S. Carroll, Hikaru Seki, Andrew J. Counsell, Abigail R. Hanby and Yuri Takada and has published in prestigious journals such as Chemical Society Reviews, Chemical Communications and Chemical Science.

In The Last Decade

Jonathan D. Bargh

9 papers receiving 977 citations

Hit Papers

Cleavable linkers in antibody–drug conjugates 2019 2026 2021 2023 2019 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cleavable linkers in antibody–drug conjugates
    2019 443 citations Jonathan D. Bargh, Albert Isidro‐Llobet et al. Chemical Society Reviews profile →
  2. Site-selective modification strategies in antibody–drug conjugates
    2020 315 citations Stephen J. Walsh, Jonathan D. Bargh et al. Chemical Society Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan D. Bargh United Kingdom 9 597 549 452 260 73 9 1.0k
Jocelyn R. Setter United States 8 791 1.3× 758 1.4× 495 1.1× 219 0.8× 87 1.2× 13 1.2k
Sharon Wilhelm United States 13 859 1.4× 802 1.5× 398 0.9× 192 0.7× 93 1.3× 20 1.2k
Robyn M. Barfield United States 17 556 0.9× 559 1.0× 609 1.3× 319 1.2× 56 0.8× 25 1.0k
Yasuaki Anami United States 14 592 1.0× 473 0.9× 365 0.8× 124 0.5× 74 1.0× 22 1.0k
Barbara A. Leece United States 12 807 1.4× 763 1.4× 386 0.9× 181 0.7× 104 1.4× 17 1.2k
Alberto Dal Corso Italy 18 411 0.7× 378 0.7× 637 1.4× 316 1.2× 93 1.3× 39 1.0k
Samuele Cazzamalli Switzerland 19 601 1.0× 454 0.8× 710 1.6× 289 1.1× 97 1.3× 57 1.2k
Scott C. Jeffrey United States 16 990 1.7× 967 1.8× 777 1.7× 356 1.4× 113 1.5× 33 1.6k
Michael Torgov United States 11 983 1.6× 941 1.7× 639 1.4× 167 0.6× 117 1.6× 19 1.6k
Sander M. J. van Duijnhoven Netherlands 16 188 0.3× 365 0.7× 528 1.2× 288 1.1× 142 1.9× 23 889

Countries citing papers authored by Jonathan D. Bargh

Since Specialization
Citations

This map shows the geographic impact of Jonathan D. Bargh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan D. Bargh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan D. Bargh more than expected).

Fields of papers citing papers by Jonathan D. Bargh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan D. Bargh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan D. Bargh. The network helps show where Jonathan D. Bargh may publish in the future.

Co-authorship network of co-authors of Jonathan D. Bargh

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan D. Bargh. A scholar is included among the top collaborators of Jonathan D. Bargh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan D. Bargh. Jonathan D. Bargh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ashman, Nicola, Jonathan D. Bargh, Stephen J. Walsh, et al.. (2023). Peroxide-cleavable linkers for antibody–drug conjugates. Chemical Communications. 59(13). 1841–1844. 17 indexed citations
2.
Ashman, Nicola, Jonathan D. Bargh, & David R. Spring. (2022). Non-internalising antibody–drug conjugates. Chemical Society Reviews. 51(22). 9182–9202. 67 indexed citations
3.
Walsh, Stephen J., Anders Højgaard Hansen, Jonathan D. Bargh, et al.. (2022). All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading. Chemical Science. 13(30). 8781–8790. 20 indexed citations
4.
Bargh, Jonathan D., Stephen J. Walsh, Nicola Ashman, et al.. (2021). A dual-enzyme cleavable linker for antibody–drug conjugates. Chemical Communications. 57(28). 3457–3460. 31 indexed citations
5.
Seki, Hikaru, Stephen J. Walsh, Jonathan D. Bargh, et al.. (2021). Rapid and robust cysteine bioconjugation with vinylheteroarenes. Chemical Science. 12(26). 9060–9068. 28 indexed citations
6.
Walsh, Stephen J., Jessica Iegre, Hikaru Seki, et al.. (2020). General dual functionalisation of biomacromolecules via a cysteine bridging strategy. Organic & Biomolecular Chemistry. 18(22). 4224–4230. 22 indexed citations
7.
Walsh, Stephen J., Jonathan D. Bargh, Abigail R. Hanby, et al.. (2020). Site-selective modification strategies in antibody–drug conjugates. Chemical Society Reviews. 50(2). 1305–1353. 315 indexed citations breakdown →
8.
Bargh, Jonathan D., Stephen J. Walsh, Albert Isidro‐Llobet, et al.. (2020). Sulfatase-cleavable linkers for antibody-drug conjugates. Chemical Science. 11(9). 2375–2380. 59 indexed citations
9.
Bargh, Jonathan D., Albert Isidro‐Llobet, Jeremy S. Parker, & David R. Spring. (2019). Cleavable linkers in antibody–drug conjugates. Chemical Society Reviews. 48(16). 4361–4374. 443 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jocelyn R. Setter Breakdown of academic impact, for papers by Sharon Wilhelm Breakdown of academic impact, for papers by Robyn M. Barfield Breakdown of academic impact, for papers by Yasuaki Anami Breakdown of academic impact, for papers by Barbara A. Leece Breakdown of academic impact, for papers by Alberto Dal Corso Breakdown of academic impact, for papers by Samuele Cazzamalli Breakdown of academic impact, for papers by Scott C. Jeffrey Breakdown of academic impact, for papers by Michael Torgov Breakdown of academic impact, for papers by Sander M. J. van Duijnhoven
Rankless by CCL
2026